Thomas J. Schnitzer

606 total citations
11 papers, 496 citations indexed

About

Thomas J. Schnitzer is a scholar working on Pharmacology, Rheumatology and Physiology. According to data from OpenAlex, Thomas J. Schnitzer has authored 11 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Rheumatology and 4 papers in Physiology. Recurrent topics in Thomas J. Schnitzer's work include Inflammatory mediators and NSAID effects (6 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Pain Mechanisms and Treatments (4 papers). Thomas J. Schnitzer is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Pain Mechanisms and Treatments (4 papers). Thomas J. Schnitzer collaborates with scholars based in United States, Australia and France. Thomas J. Schnitzer's co-authors include Elliot Ehrich, James A. Bolognese, William H. Olson, Marc Kamin, Joel A. Block, Beth C. Seidenberg, Roy Fleischmann, Qi Zeng, Ifaz T. Haider and W. Brent Edwards and has published in prestigious journals such as Osteoporosis International, Osteoarthritis and Cartilage and Clinical Therapeutics.

In The Last Decade

Thomas J. Schnitzer

9 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Schnitzer United States 9 232 171 140 77 51 11 496
Glenn C. Pixton United States 12 168 0.7× 165 1.0× 63 0.5× 115 1.5× 175 3.4× 44 559
Nurettin Taştekin Türkiye 11 123 0.5× 130 0.8× 65 0.5× 22 0.3× 149 2.9× 27 433
Alan P. Alfano United States 13 135 0.6× 22 0.1× 244 1.7× 52 0.7× 145 2.8× 23 700
Alan Moore Switzerland 13 136 0.6× 103 0.6× 156 1.1× 28 0.4× 528 10.4× 28 1.0k
Mehmet Ayhan Karakoç Türkiye 10 93 0.4× 104 0.6× 29 0.2× 57 0.7× 159 3.1× 34 490
Shaloo Pandhi Switzerland 8 67 0.3× 58 0.3× 28 0.2× 72 0.9× 69 1.4× 11 282
Helen Shi United States 4 95 0.4× 140 0.8× 56 0.4× 63 0.8× 9 0.2× 4 347
Shou‐Hung Tang Taiwan 13 106 0.5× 116 0.7× 221 1.6× 31 0.4× 26 0.5× 41 523
Ji Hyun Lee South Korea 11 89 0.4× 55 0.3× 25 0.2× 36 0.5× 142 2.8× 19 323

Countries citing papers authored by Thomas J. Schnitzer

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Schnitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Schnitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Schnitzer more than expected).

Fields of papers citing papers by Thomas J. Schnitzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Schnitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Schnitzer. The network helps show where Thomas J. Schnitzer may publish in the future.

Co-authorship network of co-authors of Thomas J. Schnitzer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Schnitzer. A scholar is included among the top collaborators of Thomas J. Schnitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Schnitzer. Thomas J. Schnitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Morse, Leslie R., William A. Bauman, B. Catharine Craven, et al.. (2025). International Spinal Cord Injury Fracture History Extended Data Set. Topics in Spinal Cord Injury Rehabilitation. 31(3). 121–128.
2.
3.
Haider, Ifaz T., et al.. (2018). Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time. Osteoporosis International. 29(12). 2703–2715. 31 indexed citations
4.
Jin, Yan, Claire Smith, David Monteith, et al.. (2018). CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial. Osteoarthritis and Cartilage. 26(12). 1609–1618. 40 indexed citations
5.
Losina, Elena, Jonas Ranstam, John Collins, Thomas J. Schnitzer, & J.N. Katz. (2015). OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis. Osteoarthritis and Cartilage. 23(5). 677–685. 25 indexed citations
6.
Graverand, M.-P. Hellio Le, R. Buck, Bradley T. Wyman, et al.. (2009). Subregional femorotibial cartilage morphology in women – comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis. Osteoarthritis and Cartilage. 17(9). 1177–1185. 46 indexed citations
7.
Bolognese, James A., Thomas J. Schnitzer, & Elliot Ehrich. (2003). Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement. Osteoarthritis and Cartilage. 11(7). 499–507. 113 indexed citations
8.
Schnitzer, Thomas J., Sheldon X. Kong, Panagiotis Mavros, Walter L. Straus, & Douglas J. Watson. (2001). Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2—selective inhibitors: analysis of a large United States claims database. Clinical Therapeutics. 23(12). 1984–1998. 21 indexed citations
9.
Schnitzer, Thomas J., Marc Kamin, & William H. Olson. (1999). Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study. Arthritis & Rheumatism. 42(7). 1370–1377. 80 indexed citations
10.
Schnitzer, Thomas J., Roy Fleischmann, Joel A. Block, et al.. (1999). The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Clinical Therapeutics. 21(10). 1688–1702. 110 indexed citations
11.
Schnitzer, Thomas J.. (1993). Osteoarthritis treatment update. Postgraduate Medicine. 93(1). 89–95. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glenn C. Pixton Breakdown of academic impact, for papers by Nurettin Taştekin Breakdown of academic impact, for papers by Alan P. Alfano Breakdown of academic impact, for papers by Alan Moore Breakdown of academic impact, for papers by Mehmet Ayhan Karakoç Breakdown of academic impact, for papers by Shaloo Pandhi Breakdown of academic impact, for papers by Helen Shi Breakdown of academic impact, for papers by Shou‐Hung Tang Breakdown of academic impact, for papers by Ji Hyun Lee
Rankless by CCL
2026